SLC3A2 and liver cancer: Dihydroartemisinin promotes the antiproliferation and ferroptosis of liver cancer cells by upregulating the ferroptosis-inducing ATF4 gene and downregulating ferroptosis-inhibiting genes (GPX4, SLC7A11, and SLC3A2) [70].